These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus. Al-Kuraishy HM; Al-Gareeb AI; Alblihed M; Guerreiro SG; Cruz-Martins N; Batiha GE Front Cardiovasc Med; 2021; 8():644095. PubMed ID: 34124187 [TBL] [Abstract][Full Text] [Related]
4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
5. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets? Sallenave JM; Guillot L Front Immunol; 2020; 11():1229. PubMed ID: 32574272 [TBL] [Abstract][Full Text] [Related]
6. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system. Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662 [TBL] [Abstract][Full Text] [Related]
7. Alterations in the gene expression of SARS-COV-2 entry receptors and enzymes in lungs and hearts of controlled and uncontrolled diabetic mice. Alkhawaldeh O; Jarrar Y; Gharaibeh M; Abudahab S; Abulebdah D; Jarrar B Fundam Clin Pharmacol; 2024 Apr; 38(2):328-340. PubMed ID: 37950353 [TBL] [Abstract][Full Text] [Related]
8. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte. D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19. Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500 [TBL] [Abstract][Full Text] [Related]
10. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart. Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018 [TBL] [Abstract][Full Text] [Related]
11. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110 [TBL] [Abstract][Full Text] [Related]
12. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin. Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873 [TBL] [Abstract][Full Text] [Related]
13. Metainflammation in COVID-19. Bakhtiari M; Asadipooya K Endocr Metab Immune Disord Drug Targets; 2022; 22(12):1154-1166. PubMed ID: 34983356 [TBL] [Abstract][Full Text] [Related]
14. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications. Davidson AM; Wysocki J; Batlle D Hypertension; 2020 Nov; 76(5):1339-1349. PubMed ID: 32851855 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199 [TBL] [Abstract][Full Text] [Related]
16. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19. Li K; Meyerholz DK; Bartlett JA; McCray PB mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553 [TBL] [Abstract][Full Text] [Related]
17. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators. Gkogkou E; Barnasas G; Vougas K; Trougakos IP Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update. Shukla AK; Banerjee M High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533 [TBL] [Abstract][Full Text] [Related]
19. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients. Subbaram K; Ali PSS; Ali S Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090 [TBL] [Abstract][Full Text] [Related]
20. Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients. Kumar A; Faiq MA; Pareek V; Raza K; Narayan RK; Prasoon P; Kumar P; Kulandhasamy M; Kumari C; Kant K; Singh HN; Qadri R; Pandey SN; Kumar S Med Hypotheses; 2020 Nov; 144():110271. PubMed ID: 33254575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]